Zomedica Corp. Insider Trading

ZOMDF

⊜ Compare

Last 12 months

Insiders bought 194K on the open market and sold nothing.

Net open-market

+194K

9 buys · 0 sales

Under a 10b5-1 plan

—

no sales

Insiders who bought / sold

3 / 0

executives and directors

Last open-market buy

May 2026

May 21, 2026

Get an email when ZOMDF's executives or directors buy, or make a large sale outside a plan.

Trades · last 2 years

Date	Insider	Trade	Shares	Price	Value	Of their stake	Filing
May 21	Russell Kevin Klass Sr. Vice President, Sales	Bought	104,000	$0.10	10K	1.7%	Form 4
May 20 – 21	Russell Kevin Klass Other	Bought 3 parts	216,899	$0.11 average	24K	3.7%	Form 4
May 18 – 20	Johnny D Powers Director	Bought 3 parts	200,000	$0.10 average	20K	4.7%	Form 4
May 12 – 13	Johnny D Powers Director	Bought 2 parts	300,000	$0.11 average	33K	7.6%	Form 4
May 8 – 11	Johnny D Powers Director	Bought 2 parts	500,000	$0.11 average	55K	15%	Form 4
May 8	Larry C Heaton II CEO	Bought	250,000	$0.11	28K	25%	Form 4
Nov 13, 2025	Russell Kevin Klass Sr Vice President, Sales	Bought	150,000	$0.10	15K	2.7%	Form 4
Nov 10, 2025	Russell Kevin Klass Sr Vice President, Sales	Bought	120,000	$0.10	12K	2.2%	Form 4
Nov 7, 2025	Russell Kevin Klass Sr Vice President, Sales	Bought	5,000	$0.10	$500	<0.1%	Form 4
Nov 6, 2025	Russell Kevin Klass Sr Vice President, Sales	Bought	253,007	$0.08	20K	4.8%	Form 4
Aug 11, 2025 – Aug 12, 2025	Russell Kevin Klass Sr Vice President, Sales	Bought 3 parts	1,056,064	$0.04 average	42K	25%	Form 4
Aug 11, 2025	Russell Kevin Klass Sr Vice President of Sales	Bought 2 parts	500,000	$0.04 average	20K	14%	Form 4
Aug 8, 2025	Russell Kevin Klass Sr Vice President of Sales	Bought	500,000	$0.04	20K	16%	Form 4
May 21, 2025	Anthony K Blair COO	Bought 2 parts	100,000	$0.05 average	5K	11%	Form 4
May 19, 2025	Karen Dehaan-Fullerton General Counsel/Corporate Secy	Bought	104,300	$0.05	5K	New	Form 4
May 19, 2025	Johnny D Powers Director	Bought	500,000	$0.05	25K	17%	Form 4
Mar 17, 2025	Jeffrey M Rowe Director	Bought 6 parts	1,439,005	$0.07 average	96K	12%	Form 4
Mar 17, 2025	Rodney James Williams Director	Bought	100,000	$0.07	7K	50%	Form 4
Mar 17, 2025	Scott Jordan Chief Financial Officer	Bought	300,000	$0.06	18K	New	Form 4
Mar 17, 2025	Christopher Ross Macleod Director	Bought	143,000	$0.06	9K	New	Form 4
Mar 17, 2025	Johnny D Powers Director	Bought 6 parts	500,000	$0.07 average	35K	21%	Form 4
Mar 17, 2025	Larry C Heaton II CEO	Bought 4 parts	500,000	$0.06 average	30K	100%	Form 4
Mar 17, 2025	Anthony K Blair COO	Bought	500,000	$0.06	30K	125%	Form 4
Mar 17, 2025	Russell Kevin Klass Sr Vice President of Sales	Bought	699,980	$0.07	49K	28%	Form 4
Mar 17, 2025	Rodney James Williams Director	Bought	100,000	$0.07	7K	250%	Form 4
Nov 11, 2024	Johnny D Powers Director	Bought	100,000	$0.12	12K	4.3%	Form 4
Nov 11, 2024	Larry C Heaton II CEO	Bought	100,000	$0.12	12K	25%	Form 4
Nov 11, 2024	Russell Kevin Klass Vice President of Sales	Bought 2 parts	500,000	$0.12 average	60K	50%	Form 4
Nov 8, 2024	Anthony K Blair COO	Bought	150,000	$0.12	18K	60%	Form 4

May 21
Russell Kevin Klass
Sr. Vice President, Sales · bought 104,000 at $0.10
10K
1.7% of stake
May 20 – 21
Russell Kevin Klass
Other · bought 216,899 at avg $0.11
24K
3.7% of stake
May 18 – 20
Johnny D Powers
Director · bought 200,000 at avg $0.10
20K
4.7% of stake
May 12 – 13
Johnny D Powers
Director · bought 300,000 at avg $0.11
33K
7.6% of stake
May 8 – 11
Johnny D Powers
Director · bought 500,000 at avg $0.11
55K
15% of stake
May 8
Larry C Heaton II
CEO · bought 250,000 at $0.11
28K
25% of stake
Nov 13, 2025
Russell Kevin Klass
Sr Vice President, Sales · bought 150,000 at $0.10
15K
2.7% of stake
Nov 10, 2025
Russell Kevin Klass
Sr Vice President, Sales · bought 120,000 at $0.10
12K
2.2% of stake
Nov 7, 2025
Russell Kevin Klass
Sr Vice President, Sales · bought 5,000 at $0.10
$500
<0.1% of stake
Nov 6, 2025
Russell Kevin Klass
Sr Vice President, Sales · bought 253,007 at $0.08
20K
4.8% of stake
Aug 11, 2025 – Aug 12, 2025
Russell Kevin Klass
Sr Vice President, Sales · bought 1,056,064 at avg $0.04
42K
25% of stake
Aug 11, 2025
Russell Kevin Klass
Sr Vice President of Sales · bought 500,000 at avg $0.04
20K
14% of stake
Aug 8, 2025
Russell Kevin Klass
Sr Vice President of Sales · bought 500,000 at $0.04
20K
16% of stake
May 21, 2025
Anthony K Blair
COO · bought 100,000 at avg $0.05
5K
11% of stake
May 19, 2025
Karen Dehaan-Fullerton
General Counsel/Corporate Secy · bought 104,300 at $0.05
5K
New position
May 19, 2025
Johnny D Powers
Director · bought 500,000 at $0.05
25K
17% of stake
Mar 17, 2025
Jeffrey M Rowe
Director · bought 1,439,005 at avg $0.07
96K
12% of stake
Mar 17, 2025
Rodney James Williams
Director · bought 100,000 at $0.07
7K
50% of stake
Mar 17, 2025
Scott Jordan
Chief Financial Officer · bought 300,000 at $0.06
18K
New position
Mar 17, 2025
Christopher Ross Macleod
Director · bought 143,000 at $0.06
9K
New position
Mar 17, 2025
Johnny D Powers
Director · bought 500,000 at avg $0.07
35K
21% of stake
Mar 17, 2025
Larry C Heaton II
CEO · bought 500,000 at avg $0.06
30K
100% of stake
Mar 17, 2025
Anthony K Blair
COO · bought 500,000 at $0.06
30K
125% of stake
Mar 17, 2025
Russell Kevin Klass
Sr Vice President of Sales · bought 699,980 at $0.07
49K
28% of stake
Mar 17, 2025
Rodney James Williams
Director · bought 100,000 at $0.07
7K
250% of stake
Nov 11, 2024
Johnny D Powers
Director · bought 100,000 at $0.12
12K
4.3% of stake
Nov 11, 2024
Larry C Heaton II
CEO · bought 100,000 at $0.12
12K
25% of stake
Nov 11, 2024
Russell Kevin Klass
Vice President of Sales · bought 500,000 at avg $0.12
60K
50% of stake
Nov 8, 2024
Anthony K Blair
COO · bought 150,000 at $0.12
18K
60% of stake

How to read this. Insiders sell for many reasons: taxes, diversifying, a house. Open-market buys are rarer and say more. A 10b5-1 plan is a trading schedule set up months in advance, so those sales were not timed on news. Large holders (funds and 10% owners) are listed under Everything but not counted as insiders. If you own or watch ZOMDF, we send a push when an executive buys or makes a large sale outside a plan.

Source: SEC Form 4 filings, filed within two business days of each trade and checked for new ones every hour.

Peers

Pharmaceutical Preparations · Pick stocks to compare with ZOMDF

CompareIntrinsic value

VTVTvTv Therapeutics Inc.

$24.03+2.04%40

FHTXFoghorn Therapeutics Inc.

$2.10-1.41%40

ZYMEZymeworks Inc.

$30.98+2.82%10

CUECue Biopharma, Inc.

$19.84-4.89%40

ETSTEarth Science Tech Inc.

$0.10+0.00%72

SBFMSunshine Biopharma Inc.

$2.65-3.28%40

LIFDLftd Partners Inc.

$0.11+0.00%35

ENVBEnveric Biosciences Inc.

$1.46-2.67%21

Spot a number that looks wrong? Check it in ZOMDF's SEC filings or

Download this analysis as a PDF (Pro)

Data sourced from SEC EDGAR filings and third-party price providers. Scores, valuations, and metrics are algorithmic estimates. This is not investment advice. See our Terms and Methodology.

2 of 2 free stocks used today

Keep analysing ZOMDF

Create a free account and get 14 days of Premium: every stock and every tool.

Unlimited stocksQuality, fair value and dividends for 10,000+ stocks
Stock screenerFilter on quality, valuation and dividend safety
Portfolio trackerReal return, dividend calendar and portfolio quality
Editable DCFChange the assumptions and watch fair value move
Compare side by sideUp to 10 stocks in one table
Unlimited alertsPrice, P/E, Quality Score and yield

No card. Moves to Free after, unless you upgrade.

Already have an account?

Or come back tomorrow. Stocks on your watchlist are always free to view.